Hedge Fund - Stonepine Capital

Manager biography is currently missing.

Fund Profile

Filing Period:

Top 13F Holdings

Filing Period:

Last updated on February 14, 2023 based on SEC 13F filings Last update: February 14, 2023

No.	Security	Ticker	Shares	Value (x$1000)	Activity	% Port
1.	Amryt Pharma Plc	AMYT	6,333,239	$46,232,645	+2%	19.44%
2.	Apollo Endosurgery Inc.	APEN	3,726,584	$37,154,042	+32%	15.62%
3.	Cti Biopharma Corp	CTIC	4,934,100	$29,653,941	-13%	12.47%
4.	Adma Biologics Inc.	ADMA	6,940,000	$26,927,200	+39%	11.32%
5.	Quidelortho Corp		300,000	$25,701,000	-41%	10.81%

Latest 13D & 13G Filings

Symbol	Company	Filed By	Filing Date	Filing
ADMA	Adma Biologics Inc.	Stonepine Capital	2022-02-14	13G Filing
ADMS	Adamas Pharmaceuticals Inc	Stonepine Capital	2022-02-14	13G Filing
KA	Kineta Inc.	Stonepine Capital	2022-02-14	13G Filing
CTIC	Cti Biopharma Corp	Stonepine Capital	2022-02-14	13G Filing
XGN	Exagen Inc.	Stonepine Capital	2022-02-14	13G Filing

News, Interviews and Investor Letters

Timothy P. Lynch's Stonepine Capital Portfolio: Top 10 Healthcare Stocks